EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decoding Thalamic Glial Interplay in Multiple Sclerosis Through Proton Magnetic Resonance Spectroscopy and Positron Emission Tomography

Firat Kara iD, Nur Neyal, Michael G Kamykowski, Christopher G Schwarz, June Kendall-Thomas, Holly A Morrison, Matthew L Senjem, Scott A Przybelski, Angela J Fought, John D Port iD, Dinesh K Deelchand iD, Val J Lowe iD und 4 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Firat Kara und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Thalamus, Positron-Emission Tomography, Multiple Sclerosis, Neuroglia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study assesses the relationship between thalamic proton-MR spectroscopy (1H-MRS) metabolites and thalamic 11C-ER176 translocator-protein positron emission tomography (TSPO-PET) standardized uptake value ratios (SUVR) to advance our understanding of thalamic involvement in multiple sclerosis (MS)-associated neurodegeneration and disability. In this prospective cross-sectional study, patients with MS (pwMS) and controls underwent 3T-MRI, 1H-MRS, and 11C-ER176-PET targeting the thalamus. MRI-derived thalamic volume was normalized by intracranial volume. 1H-MRS metabolites—N-acetylaspartate (NAA), glutamate (Glu), glutamine (Gln), total choline (tCho), and myo-inositol (mIns)—were normalized to total creatine (tCr). Clinical disability was evaluated using MS-specific tests of Expanded Disability Status Scale-EDSS and MS-functional composite-MSFC (including Paced Auditory Serial Addition Test-PASAT). Compared to controls (n = 30), pwMS (n = 21) exhibited smaller thalamic volume, higher thalamic 1H-MRS mIns/tCr (putative gliosis marker), and higher thalamic 11C-ER176-PET SUVR (glial density marker). In pwMS, higher thalamic mIns/tCr (r = −0.67) and tCho/tCr (r = −0.52) correlated with smaller thalamic volume. In pwMS, higher thalamic mIns/tCr correlated with higher thalamic 11C-ER176-PET SUVR (r = 0.48) and decreased cognitive function (PASAT, rho = −0.48). In controls, decreased thalamic NAA/tCr correlated with increased thalamic 11C-ER176-PET SUVR (r = −0.41). Thalamus, a core central nervous system relay, is affected early in MS disease course. Glial-mediated innate immune activation in the thalamus, evaluated by increased 1H-MRS mIns/tCr and 11C-ER176-PET SUVR, is associated with loss of thalamic volume and increased disability in pwMS. The multimodal imaging approach with 1H-MRS mIns/tCr and 11C-ER176-PET SUVR emerges as potential glial biomarkers, to better understand disease mechanisms and evaluate therapeutic interventions targeting glial activity in MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThalamusPositron-Emission TomographyMultiple SclerosisNeurogliaProton Magnetic Resonance SpectroscopyHumansFemaleMaleAdultMiddle AgedCross-Sectional StudiesProspective Studies

Stichwörter der Autor:innen

11C-ER176 TSPO positron emission tomographygliosismultiple sclerosisproton magnetic resonance spectroscopythalamus

Autor:innen und Institutionen

  • Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Information Technology, Mayo Clinic, Rochester, MN 55905, USA.
  • Mayo Clinic Center for MS and Autoimmune Neurology, Rochester, MN 55905, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
  • Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN 55455, USA.
  • Mayo Clinic Women's Health Research Center, Rochester, MN 55905, USA.

ORCID-Profile: Firat Kara, John D Port, Dinesh K Deelchand, Val J Lowe, Gülin Öz, Burcu Zeydan

Förderung

  • NIBIB NIH HHS
  • NIH HHS
  • NICHD NIH HHS
  • NINDS NIH HHS
  • NIAMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Kara, F., Neyal, N., Kamykowski, M. G., Schwarz, C. G., Kendall-Thomas, J., Morrison, H. A., Senjem, M. L., Przybelski, S. A., Fought, A. J., Port, J. D., Deelchand, D. K., Lowe, V. J., Öz, G., Kantarci, K., Kantarci, O. H., & Zeydan, B. (2025). Decoding Thalamic Glial Interplay in Multiple Sclerosis Through Proton Magnetic Resonance Spectroscopy and Positron Emission Tomography. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178656

Vancouver

Kara F, Neyal N, Kamykowski MG, Schwarz CG, Kendall-Thomas J, Morrison HA, et al. Decoding Thalamic Glial Interplay in Multiple Sclerosis Through Proton Magnetic Resonance Spectroscopy and Positron Emission Tomography. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178656

BibTeX
@article{Kara2025,
  author = {Kara, Firat and Neyal, Nur and Kamykowski, Michael G and Schwarz, Christopher G and Kendall-Thomas, June and Morrison, Holly A and Senjem, Matthew L and Przybelski, Scott A and Fought, Angela J and Port, John D and Deelchand, Dinesh K and Lowe, Val J and Öz, Gülin and Kantarci, Kejal and Kantarci, Orhun H and Zeydan, Burcu},
  title = {Decoding Thalamic Glial Interplay in Multiple Sclerosis Through Proton Magnetic Resonance Spectroscopy and Positron Emission Tomography},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178656}
}
Kostenlos starten →